Erschienen in:
08.10.2018 | ASO Author Reflections
ASO Author Reflections: Hepatic Artery Infusion (HAI) Chemotherapy is Associated with Improved Survival Compared with Radioembolization (Y90) in Patients with Isolated Unresectable Colorectal Liver Metastases
Erschienen in:
Annals of Surgical Oncology
|
Sonderheft 3/2018
Einloggen, um Zugang zu erhalten
Excerpt
Modern chemotherapy forms the backbone of treatment for isolated unresectable colorectal liver metastases (IU-CRLM). Although response rates can exceed 60% in the first-line systemic setting, second-line chemotherapy regimens are associated with poor response rates (20–30%) and median survival of 1 year. Although hepatic artery infusion (HAI) therapy and yttrium-90 radioembolization (Y90) are used in patients with IU-CRLM,
1,
2 there are no data on the comparative effectiveness of either regional modality when used in conjunction with modern chemotherapy. Additionally, cost analysis of either regional modality has not been performed. In this study, we compared the overall survival (OS) of second-line HAI versus Y90 for IU-CRCLM patients treated with modern chemotherapy and performed a cost analysis of both regional modalities. …